ARSENALBIO Trademark

Trademark Overview

On Friday, March 26, 2021, a trademark application was filed for ARSENALBIO with the United States Patent and Trademark Office. The USPTO has given the ARSENALBIO trademark a serial number of 90606669. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, June 26, 2024. This trademark is owned by Arsenal Biosciences, Inc.. The ARSENALBIO trademark is filed in the Pharmaceutical Products category with the following description:

Biologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions
arsenalbio

General Information

Serial Number90606669
Word MarkARSENALBIO
Filing DateFriday, March 26, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, June 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 7, 2021

Trademark Statements

Goods and ServicesBiologics for medical use, namely, biologics for the assessment of treatment options for solid tumors; biologics for medical use, namely, biologics for the assessment of treatment options for oncological and infectious diseases, disorders and conditions; biologics for medical purposes, namely, biologics for detecting the presence of malignant diseases, disorders and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArsenal Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameArsenal Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, March 30, 2021NEW APPLICATION ENTERED
Friday, July 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Thursday, November 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 27, 2022SOU EXTENSION 1 FILED
Wednesday, July 27, 2022SOU EXTENSION 1 GRANTED
Friday, January 27, 2023SOU EXTENSION 2 FILED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 27, 2023SOU TEAS EXTENSION RECEIVED
Friday, January 27, 2023SOU EXTENSION 2 GRANTED
Tuesday, January 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 26, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 26, 2023SOU EXTENSION 3 FILED
Wednesday, July 26, 2023SOU EXTENSION 3 GRANTED
Friday, July 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 24, 2024SOU EXTENSION 4 FILED
Wednesday, January 24, 2024SOU EXTENSION 4 GRANTED
Friday, March 1, 2024TEAS REQUEST TO DIVIDE RECEIVED
Thursday, March 21, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2024SOU EXTENSION 5 FILED
Friday, March 1, 2024DIVISIONAL REQUEST RECEIVED
Friday, March 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 27, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, June 27, 2024SOU EXTENSION 5 GRANTED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

arsenalbio biologics namely medical disorders conditions treatment assessment diseases options malignant